Know Cancer

or
forgot password

Predictive Factors for Major Bleeding Risk in Patients Admitted in a Palliativecare Unit - Etude RHESO - Etude Monocentrique


N/A
18 Years
N/A
Open (Enrolling)
Both
Hemorrhage

Thank you

Trial Information

Predictive Factors for Major Bleeding Risk in Patients Admitted in a Palliativecare Unit - Etude RHESO - Etude Monocentrique


Inclusion Criteria:



- 18 years

- admitted in a palliative care unit for a cancer, a pulmonary, a cardiac or a
neurologic advanced disease

Exclusion Criteria:

- life prognosis less than 48 hours

- patients treated with curative doses of antithrombotic therapy

- patients with follow up of 3 months is not possible

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

The primary outcome is the symptomatic occurrence of major and clinical relevant bleeding during the three months study period.

Outcome Time Frame:

3 month

Safety Issue:

No

Principal Investigator

Bernard TARDY, PHD

Investigator Role:

Study Director

Investigator Affiliation:

CIC-EC (CIE3)

Authority:

France: French Data Protection Authority

Study ID:

0908039

NCT ID:

NCT01056978

Start Date:

April 2010

Completion Date:

October 2012

Related Keywords:

  • Hemorrhage
  • palliative care unit
  • bleeding
  • thromboembolic
  • hemorrhagic risk
  • antithrombotic prophylaxis
  • Hemorrhage

Name

Location